First Republic Investment Management, Inc. Abbott Laboratories Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 1,644,689 shares of ABT stock, worth $191 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

1,644,689

Previous 1,799,916 8.62%

Holding current value

$191 Million

Previous $196 Million 18.82%

% of portfolio

0.46%

Previous 1.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $14.8 Million - $17.8 Million	-155,227 Reduced 8.62%	1,644,689 $159 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $45.6 Million - $50.8 Million	-451,979 Reduced 20.07%	1,799,916 $196 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $23.3 Million - $27.5 Million	240,889 Added 11.98%	2,251,895 $228 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $8.83 Million - $10.4 Million	-92,838 Reduced 4.41%	2,011,006 $221 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $19.4 Million - $22.5 Million	200,586 Added 10.54%	2,103,844 $204 Million
Q2 2022 Aug 16, 2022	BUY	$102.07 - $123.37 $60.7 Million - $73.3 Million	594,315 Added 45.4%	1,903,258 $207 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $5.84 Million - $7.12 Million	51,200 Added 4.07%	1,308,943 $155 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $9.13 Million - $11.2 Million	78,998 Added 6.7%	1,257,743 $177 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $3.91 Million - $4.33 Million	-33,517 Reduced 2.76%	1,178,745 $139 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $4.03 Million - $4.74 Million	38,092 Added 3.24%	1,212,262 $141 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $6.56 Million - $7.73 Million	-60,293 Reduced 4.88%	1,174,170 $141 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.18 Million - $1.28 Million	11,223 Added 0.92%	1,234,463 $135 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $9.05 Million - $11 Million	98,772 Added 8.78%	1,223,240 $133 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $3.44 Million - $4.4 Million	44,928 Added 4.16%	1,124,468 $103 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $6.36 Million - $9.3 Million	101,243 Added 10.35%	1,079,540 $85.2 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $7.62 Million - $8.48 Million	97,081 Added 11.02%	978,297 $85 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $3.13 Million - $3.4 Million	38,263 Added 4.54%	881,216 $73.7 Million
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $1.95 Million - $2.28 Million	-26,822 Reduced 3.08%	842,953 $70.9 Million
Q1 2019 Apr 30, 2019	BUY	$66.22 - $80.06 $2.97 Million - $3.59 Million	44,835 Added 5.43%	869,775 $69.5 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $700,115 - $793,129	-10,679 Reduced 1.28%	824,940 $59.7 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $35,634 - $42,988	586 Added 0.07%	835,619 $61.3 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $750,482 - $828,307	-13,036 Reduced 1.54%	835,033 $50.9 Million
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $1.56 Million - $1.76 Million	27,717 Added 3.38%	848,069 $5.82 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $1.95 Million - $2.09 Million	36,341 Added 4.64%	820,352 $46.8 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $37.7 Million - $42.1 Million	784,011	784,011 $41.8 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Abbott Laboratories Transaction History